IBRX
ImmunityBio·NASDAQ
--
--(--)
--
--(--)
IBRX fundamentals
ImmunityBio (IBRX) released its earnings on Aug 5, 2025: revenue was 26.43M (YoY +2542.50%), beat estimates; EPS was -0.1 (YoY +50.00%), beat estimates.
Revenue / YoY
26.43M
+2542.50%
EPS / YoY
-0.1
+50.00%
Report date
Aug 5, 2025
EPS
Revenue
Revenue & Expenses
IBRX has released its 2025 Q3 earnings report, with revenue of 32.06M, reflecting a YoY change of 425.07%, and net profit of -67.27M, showing a YoY change of 21.55%. The Sankey diagram below clearly presents IBRX's revenue sources and cost distribution.
Key Indicators
ImmunityBio (IBRX) key financial stats and ratios, covering profitability, financial health, and leverage.
ImmunityBio (IBRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
ImmunityBio (IBRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
ImmunityBio (IBRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does ImmunityBio (IBRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track ImmunityBio (IBRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from ImmunityBio’s earnings call?What were the key takeaways from ImmunityBio's earnings call?Did ImmunityBio beat or miss consensus estimates last quarter?What does ImmunityBio do and what are its main business segments?What is ImmunityBio's latest dividend and current dividend yield?What guidance did ImmunityBio's management provide for the next earnings period?What factors drove the changes in ImmunityBio's revenue and profit?What is the market's earnings forecast for ImmunityBio next quarter?
